多胎妊娠合并妊娠期糖尿病进展为2型糖尿病风险更高:肥胖的影响
这项回顾性研究基于前瞻性队列,纳入2017年1月1日至2020年12月31日妊娠、随访至产后5年的61,891例产妇,比较单胎与多胎妊娠合并妊娠期糖尿病进展为2型糖尿病的风险。结果显示,合并妊娠期糖尿病时,多胎妊娠进展为2型糖尿病的调整风险比为9.26,单胎为4.62;分层分析显示该效应主要在肥胖患者中观察到。
要点
- 多胎妊娠合并妊娠期糖尿病进展为2型糖尿病的调整风险比为9.26,单胎为4.62。
- 非肥胖多胎妊娠合并妊娠期糖尿病进展风险未达统计学显著(调整风险比9.15,95%CI 0.92-90.22,P=.059)。
- 肥胖多胎妊娠合并妊娠期糖尿病进展风险调整风险比为9.31(95%CI 2.12-40.76,P=.003)。
核心结论
- 与单胎妊娠合并妊娠期糖尿病相比,多胎妊娠合并妊娠期糖尿病使进展为2型糖尿病的风险加倍,该效应主要在肥胖患者中观察到。
- 作者认为,应特别关注多胎妊娠合并妊娠期糖尿病患者,尤其是肥胖者,并进行产后随访,以便早期诊断和干预2型糖尿病。
研究设计与样本
- 对2017年1月1日至2020年12月31日期间妊娠的前瞻性队列进行回顾性研究,随访至产后5年。
- 共88,611例产妇中61,891例符合纳入标准,分为单胎无妊娠期糖尿病、单胎合并妊娠期糖尿病、多胎无妊娠期糖尿病和多胎合并妊娠期糖尿病4组。
- 妊娠期糖尿病采用美国糖尿病协会(American Diabetes Association)标准的两步法定义。
- 采用单因素分析、Kaplan-Meier风险曲线和Cox比例风险模型计算进展为2型糖尿病的调整风险比及95%置信区间。
主要发现
- 单胎合并妊娠期糖尿病组2型糖尿病患病率为6.5%,多胎合并妊娠期糖尿病组为9.4%。
- 合并妊娠期糖尿病的产妇无论胎数均年龄更大且孕早期空腹血糖更高。
- 单胎妊娠中,妊娠期糖尿病组体重指数升高、高血压和分娩孕周更早的比例显著更高;多胎妊娠中未观察到这一差异。
- 生存分析显示,妊娠期糖尿病与2型糖尿病的调整风险比在单胎妊娠为4.62(95%CI 3.69-5.78),在多胎妊娠为9.26(95%CI 2.67-32.01),两者P<.001。
- 按肥胖状态分层:非肥胖单胎妊娠合并妊娠期糖尿病进展风险调整风险比为10.24(95%CI 6.79-15.44,P<.001),非肥胖多胎妊娠为9.15(95%CI 0.92-90.22,P=.059);肥胖单胎妊娠为3.66(95%CI 2.81-4.67,P<.001),肥胖多胎妊娠为9.31(95%CI 2.12-40.76,P=.003)。
临床怎么用
- 作者认为,应特别关注多胎妊娠合并妊娠期糖尿病患者,尤其是肥胖者,并进行产后随访,以便早期诊断和干预2型糖尿病。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The relationship between gestational diabetes mellitus and adverse outcomes in multifetal pregnancies is complex and controversial. Moreover, limited research has focused on the risk of gestational diabetes mellitus progression to type 2 diabetes mellitus specifically in multifetal pregnancies, resulting in conflicting results from existing studies. OBJECTIVE: This study aimed to assess the risk of gestational diabetes mellitus progression to type 2 diabetes mellitus between singleton and multifetal pregnancies in a large cohort of parturients with a 5-year follow-up. STUDY DESIGN: A retrospective study was conducted on a prospective cohort of pregnant individuals with pregnancies between January 1, 2017, and December 31, 2020, followed up to 5 years after delivery. Glucose levels during pregnancy were obtained from the Meuhedet Health Maintenance Organization laboratory system and cross-linked with the Israeli National Diabetes Registry. The cohort was divided into 4 groups: singleton pregnancy without gestational diabetes mellitus, singleton pregnancy with gestational diabetes mellitus, multifetal pregnancy without gestational diabetes mellitus, and multifetal pregnancy with gestational diabetes mellitus. Gestational diabetes mellitus was defined according to the American Diabetes Association criteria using the 2-step strategy. Univariate analyses, followed by survival analysis that included Kaplan-Meier hazard curves and Cox proportional-hazards models, were used to assess differences between groups and calculate the adjusted hazard ratios with 95% confidence intervals for progression to type 2 diabetes mellitus. RESULTS: Among 88,611 parturients, 61,891 cases met the inclusion criteria. The prevalence of type 2 diabetes mellitus was 6.5% in the singleton pregnancy with gestational diabetes mellitus group and 9.4% in the multifetal pregnancy with gestational diabetes mellitus group. Parturients with gestational diabetes mellitus, regardless of plurality, were older and had higher fasting plasma glucose levels in the first trimester of pregnancy. The rates of increased body mass index, hypertension, and earlier gestational age at delivery were significantly higher in the gestational diabetes mellitus group among patients with singleton pregnancies but not among patients with multifetal pregnancies. Survival analysis demonstrated that gestational diabetes mellitus was associated with adjusted hazard ratios of type 2 diabetes mellitus of 4.62 (95% confidence interval, 3.69-5.78) in singleton pregnancies and 9.26 (95% confidence interval, 2.67-32.01) in multifetal pregnancies (P<.001 for both). Stratified analysis based on obesity status revealed that, in parturients without obesity, gestational diabetes mellitus in singleton pregnancies increased the risk of type 2 diabetes mellitus by 10.24 (95% confidence interval, 6.79-15.44; P<.001) compared with a nonsignificant risk in multifetal pregnancies (adjusted hazard ratio, 9.15; 95% confidence interval, 0.92-90.22; P=.059). Among parturients with obesity, gestational diabetes mellitus was associated with an increased risk of type 2 diabetes mellitus for both singleton and multifetal pregnancies (adjusted hazard ratio, 3.66; [95% confidence interval, 2.81-4.67; P<.001] and 9.31 [95% confidence interval, 2.12-40.76; P=.003], respectively). CONCLUSION: Compared with gestational diabetes mellitus in singleton pregnancies, gestational diabetes mellitus in multifetal pregnancies doubles the risk of progression to type 2 diabetes mellitus. This effect is primarily observed in patients with obesity. Our findings underscore the importance of providing special attention and postpartum follow-up for patients with multifetal pregnancies and gestational diabetes mellitus, especially those with obesity, to enable early diagnosis and intervention for type 2 diabetes mellitus.
引用
- Naeh A, Maor-Sagie E, Hallak M, et al. Greater risk of type 2 diabetes progression in multifetal gestations with gestational diabetes: the impact of obesity. Am J Obstet Gynecol. 2024. PMID: 38360449. doi:10.1016/j.ajog.2023.11.1246
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。